By the same authors

From the same journal

From the same journal

How much should be paid for specialised treatment?

Research output: Contribution to journalArticle

Standard

How much should be paid for specialised treatment? / Daidone, Silvio; Street, Andrew David.

In: Social Science & Medicine, Vol. 84, 05.2013, p. 110-118.

Research output: Contribution to journalArticle

Harvard

Daidone, S & Street, AD 2013, 'How much should be paid for specialised treatment?', Social Science & Medicine, vol. 84, pp. 110-118. https://doi.org/10.1016/j.socscimed.2013.02.005

APA

Daidone, S., & Street, A. D. (2013). How much should be paid for specialised treatment? Social Science & Medicine, 84, 110-118. https://doi.org/10.1016/j.socscimed.2013.02.005

Vancouver

Daidone S, Street AD. How much should be paid for specialised treatment? Social Science & Medicine. 2013 May;84:110-118. https://doi.org/10.1016/j.socscimed.2013.02.005

Author

Daidone, Silvio ; Street, Andrew David. / How much should be paid for specialised treatment?. In: Social Science & Medicine. 2013 ; Vol. 84. pp. 110-118.

Bibtex - Download

@article{a7fd82ff3e9c4aac936b828a5903ed42,
title = "How much should be paid for specialised treatment?",
abstract = "English health policy has moved toward establishing specialist multi-disciplinary teams to care for patients suffering rare or particularly complex conditions. But the healthcare resource groups (HRGs), which form the basis of the prospective payment system for hospitals, do not explicitly account for specialist treatment. There is a risk, then, that hospitals in which specialist teams are based might be financially disadvantaged if patients requiring specialised care are more expensive to treat than others allocated to the same HRG. To assess this we estimate the additional costs associated with receipt of specialised care. We analyse costs for 12,154,599 patients treated in 163 English hospitals according to the type of specialised care received, if any. We account for the distributional features of patient cost data, and estimate ordinary least squares and generalised linear regression models with random effects to isolate what influence the hospital itself has on costs. We find that, for nineteen types of specialised care, patients do not have higher costs than others allocated to the same HRG. However, costs are higher if a patient has cancer, spinal, neurosciences, cystic fibrosis, children’s, rheumatology, colorectal or orthopaedic specialised services. Hospitals might be paid a surcharge for providing these forms of specialised care. We also find substantial variation in the average cost of treatment across the hospital sector, due neither to the provision of specialised care nor to other characteristics of each hospital’s patients.",
keywords = "Hospital specialisation, prospective payment systems, diagnosis related groups, healthcare resource groups, treatment costs",
author = "Silvio Daidone and Street, {Andrew David}",
note = "{\circledC} 2013 Elsevier B.V.",
year = "2013",
month = "5",
doi = "10.1016/j.socscimed.2013.02.005",
language = "English",
volume = "84",
pages = "110--118",
journal = "Social Science & Medicine",
issn = "0277-9536",
publisher = "Elsevier Limited",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - How much should be paid for specialised treatment?

AU - Daidone, Silvio

AU - Street, Andrew David

N1 - © 2013 Elsevier B.V.

PY - 2013/5

Y1 - 2013/5

N2 - English health policy has moved toward establishing specialist multi-disciplinary teams to care for patients suffering rare or particularly complex conditions. But the healthcare resource groups (HRGs), which form the basis of the prospective payment system for hospitals, do not explicitly account for specialist treatment. There is a risk, then, that hospitals in which specialist teams are based might be financially disadvantaged if patients requiring specialised care are more expensive to treat than others allocated to the same HRG. To assess this we estimate the additional costs associated with receipt of specialised care. We analyse costs for 12,154,599 patients treated in 163 English hospitals according to the type of specialised care received, if any. We account for the distributional features of patient cost data, and estimate ordinary least squares and generalised linear regression models with random effects to isolate what influence the hospital itself has on costs. We find that, for nineteen types of specialised care, patients do not have higher costs than others allocated to the same HRG. However, costs are higher if a patient has cancer, spinal, neurosciences, cystic fibrosis, children’s, rheumatology, colorectal or orthopaedic specialised services. Hospitals might be paid a surcharge for providing these forms of specialised care. We also find substantial variation in the average cost of treatment across the hospital sector, due neither to the provision of specialised care nor to other characteristics of each hospital’s patients.

AB - English health policy has moved toward establishing specialist multi-disciplinary teams to care for patients suffering rare or particularly complex conditions. But the healthcare resource groups (HRGs), which form the basis of the prospective payment system for hospitals, do not explicitly account for specialist treatment. There is a risk, then, that hospitals in which specialist teams are based might be financially disadvantaged if patients requiring specialised care are more expensive to treat than others allocated to the same HRG. To assess this we estimate the additional costs associated with receipt of specialised care. We analyse costs for 12,154,599 patients treated in 163 English hospitals according to the type of specialised care received, if any. We account for the distributional features of patient cost data, and estimate ordinary least squares and generalised linear regression models with random effects to isolate what influence the hospital itself has on costs. We find that, for nineteen types of specialised care, patients do not have higher costs than others allocated to the same HRG. However, costs are higher if a patient has cancer, spinal, neurosciences, cystic fibrosis, children’s, rheumatology, colorectal or orthopaedic specialised services. Hospitals might be paid a surcharge for providing these forms of specialised care. We also find substantial variation in the average cost of treatment across the hospital sector, due neither to the provision of specialised care nor to other characteristics of each hospital’s patients.

KW - Hospital specialisation

KW - prospective payment systems

KW - diagnosis related groups

KW - healthcare resource groups

KW - treatment costs

UR - http://www.scopus.com/inward/record.url?scp=84875366748&partnerID=8YFLogxK

U2 - 10.1016/j.socscimed.2013.02.005

DO - 10.1016/j.socscimed.2013.02.005

M3 - Article

VL - 84

SP - 110

EP - 118

JO - Social Science & Medicine

T2 - Social Science & Medicine

JF - Social Science & Medicine

SN - 0277-9536

ER -